Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Gelteq Limited - Ordinary Shares (NQ:GELS)

0.8446 -0.0200 (-2.31%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 29, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 39,207
Open 0.8646
Bid (Size) 0.8050 (200)
Ask (Size) 0.8917 (100)
Prev. Close 0.8646
Today's Range 0.7910 - 0.8790
52wk Range 0.7701 - 4.110
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Gelteq Signs Three Year Sales Agreement with Shenzhen Mana Health Management Co. Strengthening Gelteq’s Nutritional Product Expansion into China ↗
Gelteq signed a three-year agreement with Shenzhen Mana Health Management to distribute its sugar-lowering nutritional products in China, guaranteeing approximately $1.3 million in minimum revenue. 
Via Stocktwits
News headline image
Gelteq Preclinical Study Demonstrates Enhanced Oral Delivery of Oil-Soluble and Poorly Soluble Drugs Using Its Gel-Based Platform ↗
Gelteq announced preclinical results demonstrating its proprietary gel platform significantly improved the absorption and bioavailability of poorly soluble drugs. 
Via Stocktwits

Performance

YTD
-64.5%
-64.5%
1 Month
-21.8%
-21.8%
3 Month
-38.8%
-38.8%
6 Month
-51.2%
-51.2%
1 Year
-63.4%
-63.4%

More News

Read More
News headline image
Gelteq to Present at Investor Summit Virtual on December 9, 2025 ↗
Via Stocktwits
News headline image
Get insights into the top gainers and losers of Tuesday's after-hours session. ↗
Via Chartmill
Gelteq Announces Commencement of Preclinical Trial Targeting Oil Soluble Drug Market with Novel Delivery Platform ↗
Via Stocktwits
Gelteq Announces New Product Development Agreement with Melbourne Health for Novel Bowel Polyp Growth Reduction Compound ↗
Via Stocktwits
Gelteq Technology Powers U.S. Product Launches of its Nutraceutical Products for Partner ↗
Via Stocktwits
News headline image
Kartoon Studios Mainframe Studios, Toon Media, and Premium IP Pipeline Drive 2026-2027 Outlook
Via AB Newswire
News headline image
Top movers in Monday's session ↗
Via Chartmill
News headline image
The market is filled with gapping stocks in Monday's session. ↗
Via Chartmill
Gelteq Announces Commencement of Preclinical Trial for Novel Gel-Based Antihistamine Formulation Targeting Allergy Market ↗
Via Stocktwits
News headline image
Gelteq Announces Positive Preclinical Results Demonstrating Enhanced Bioavailability Using Its Proprietary Gel-Based Drug Delivery Platform ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-09-05: top gainers and losers in today's session. ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
Via Benzinga
News headline image
Friday's session: top gainers and losers ↗
Via Chartmill
News headline image
Healthy Extracts Builds Upon Record Q2 Results and Transformative Merger with Launch of New Revolutionary Hydration and Sugar Metabolism Gel-Packs
Via ACCESS Newswire
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
Via Benzinga
News headline image
Gelteq Announces Agreement with IDT Australia to Secure Dedicated New Product Development and Manufacturing Facilities ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
Via Benzinga
News headline image
Tuesday's pre-market session: top gainers and losers ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
Via Benzinga
News headline image
Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
Via Chartmill

Frequently Asked Questions

Is Gelteq Limited - Ordinary Shares publicly traded?
Yes, Gelteq Limited - Ordinary Shares is publicly traded.
What exchange does Gelteq Limited - Ordinary Shares trade on?
Gelteq Limited - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Gelteq Limited - Ordinary Shares?
The ticker symbol for Gelteq Limited - Ordinary Shares is GELS on the Nasdaq Stock Market
What is the current price of Gelteq Limited - Ordinary Shares?
The current price of Gelteq Limited - Ordinary Shares is 0.8446
When was Gelteq Limited - Ordinary Shares last traded?
The last trade of Gelteq Limited - Ordinary Shares was at 12/29/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.